Hypoxia Inducible Factor-1α Mediates the Profibrotic Effect of Albumin in Renal Tubular Cells
Affiliations
Proteinuria is closely associated with the progression of chronic kidney diseases (CKD) by producing renal tubulointerstitial fibrosis. Over-activation of hypoxia inducible factor (HIF)-1α has been implicated in the progression of CKD. The present study tested the hypothesis that HIF-1α mediates albumin-induced profibrotic effect in cultured renal proximal tubular cells. Incubation of the cells with albumin (40 μg/ml) for 72 hrs significantly increased the protein levels of HIF-1α, tissue inhibitor of metalloproteinase (TIMP)-1 and collagen-I, which were blocked by HIF-1α shRNA. Albumin also stimulated an epithelial-mesenchymal transition (EMT) as indicated by the decrease in epithelial marker E-cadherin, and the increase in mesenchymal markers α-smooth muscle actin and fibroblast-specific protein 1. HIF-1α shRNA blocked albumin-induced changes in these EMT markers as well. Furthermore, albumin reduced the level of hydroxylated HIF-1α, indicating an inhibition of the activity of prolyl-hydroxylases, enzymes promoting the degradation of HIF-1α. An anti-oxidant ascorbate reversed albumin-induced inhibition of prolyl-hydroxylase activity. Overexpression of prolyl-hydroxylase 2 (PHD2) transgene, a predominant isoform of PHDs in renal tubules, to reduce HIF-1α level significantly attenuated albumin-induced increases in TIMP-1 and collagen-I levels. These results suggest that albumin-induced oxidative stress inhibits PHD activity to accumulate HIF-1α, which mediates albumin-induced profibrotic effects in renal tubular cells.
Crosstalk between glomeruli and tubules.
Fogo A, Harris R Nat Rev Nephrol. 2024; 21(3):189-199.
PMID: 39643696 DOI: 10.1038/s41581-024-00907-0.
Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review.
Sahin A, Babayev H, Cirigliano L, Preto M, Falcone M, Altintas E Int J Impot Res. 2024; 36(8):801-808.
PMID: 38454161 DOI: 10.1038/s41443-024-00845-2.
Chellini F, Tani A, Parigi M, Palmieri F, Garella R, Zecchi-Orlandini S Cells. 2023; 12(24).
PMID: 38132171 PMC: 10742321. DOI: 10.3390/cells12242851.
Qian Q, Pan J, Yang J, Wang R, Luo K, Ma Z Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52(6):777-784.
PMID: 38105680 PMC: 10764180. DOI: 10.3724/zdxbyxb-2023-0352.
Ene C, Nicolae I J Pers Med. 2023; 13(6).
PMID: 37373923 PMC: 10304544. DOI: 10.3390/jpm13060934.